Back to the NBA website

Performance Reporting

Outcome 1 Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements

Objectives
Secure the supply of blood and blood products Improve risk management and blood sector performance Promote the safe and efficient use of blood and blood products
Deliverables

Deliverable: New Australian Red Cross Blood Service contract arrangements are progressed.

Reference Point/Target: The Deed of Agreement and the second round of the OBFM are finalised; National Service Standards, Payment and Substitution Rules and the National Inventory Management Framework are progressed.

Result: Met. Deed variation endorsed by Ministers including handover clauses and the second round of the OBFM.

Deliverable: Review of the clinical and administrative management of IVIg is progressed.

Reference Point/Target: Phase 2 to be completed by August 2012 and Phase 3 considered by the Review Advisory Group by December 2012.

Result Met. Review completed and recommendations considered by the JBC.

Deliverable: National data strategy is progressed.

Reference Point/Target:

  • Performance scorecard is agreed by December 2012.
  • Data governance arrangements finalised by June 2013.
  • Benchmarks for wastage determined by June 2013.

Result: Met. National Blood Sector Data and Information Scorecard 2013-16 Strategy was approved by JBC. Performance scorecard and shadow targets for wastage were agreed.

Key Performance Indicator: NBA funding jurisdictions are satisfied with planning, management and coordination of NBA activities.

Reference Point/Target: Satisfaction is assessed through survey of JBC members.

Result: Met. Results from 2012-13 survey indicated 83.3 per cent were satisfied that NBA met this KPI. 16.7 per cent indicated they were unsure.

Key Performance Indicator: Effective consultation with clinicians on options for the development of a comprehensive national PBM program.

Reference Point/Target: Satisfaction is assessed through surveys of all relevant stakeholders.

Result: Met. A high level of satisfaction indicated during formal consultation and feedback processes involving clinical stakeholders.

Deliverable: Clinical practice guidelines submitted for National Health and Medical Research Council (NHMRC) consideration.

Target: Two.

Result: Met. Module 3 Medical and Module 4 Critical Care of the PBM Guidelines were endorsed by NHMRC and released in 2012-13.
Objectives
Secure the supply of blood and blood products Improve risk management and blood sector performance Promote the safe and efficient use of blood and blood products
Deliverables

Key Performance Indicator: Variance between actual and NBA estimated demand for supply of products.

Target: <5 per cent.

Result: Substantially met. The demand for a number of fresh and recombinant products declined further than estimated as a result of better than anticipated take up of improved clinical practice measures.

Key Performance Indicator: Percentage of hospitals using BloodNet.

Target: 65 per cent.

Result: Met. 95 per cent of hospitals that receive blood.
Objectives
Secure the supply of blood and blood products Improve risk management and blood sector performance Promote the safe and efficient use of blood and blood products
Deliverables
  • National Supply Plan and Budget.
  • Contract Management:
    • Deed of Agreement with Blood Service.
    • CSL Australian Fractionation Agreement.
  • Review of IVIg
  • Evaluation of New Products
  • Data Developments
  • Risk Management
  • ICT Developments
  • Sector Monitoring
  • Reference Development
  • Implementation
    • Best Practice Tools
    • Promotion and Communication
    • Education and Training
  • Research and Development
Prev
Next